SpringRock Ventures is a Seattle-based venture capital firm investing at the convergence of healthcare and information technology. The firm typically deploys $2M–$5M into digital health, SaaS, medical devices, and tech-enabled services companies.
69% of their portfolio is in Healthcare. Their most common stage is series-a (41% of deals). Average disclosed round size is $24.2M (across 26 rounds with reported amounts).
Portfolio
20
Fund Size
—
Top Stage
Series A
Last 12 Mo
0
Team
Chuck Brynelsen
Venture Partner
Derek Streat
Venture Partner
Dr. Joel Berg
Venture Partner
Dr. Randy Axelrod
Venture Partner
Peter Horadan
Venture Partner
Colleen Birdnow Brown
Strategic Board Director
Dennis Weston
Strategic Board Director
Jeff Seely
Strategic Board Director
Jim Dwyer
Strategic Board Director
Lucinda Stewart
Strategic Board Director
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
Portfolio
| Company | Round | Amount | Date |
|---|---|---|---|
| KKLOwen Orthodontics | Series B | $25.5M | Jan 2026 |
 KLOwen | Series B | $25.5M | Jan 2024 |
 Proclaim | Series B | $15M | Jul 2023 |
 Dexcare | Series C | $75M | Jun 2023 |
 DexCare | Series C | $75M | Jun 2023 |
 Carrum Health | Series B | $45M | May 2023 |
 Vouched | Series A | $6.3M | Feb 2023 |
 Offor Health | Series A | $9M | Apr 2022 |
| Dexcare | Series B | $50M | Jan 2022 |
| DexCare | Series B | $50M | Jan 2022 |
| Dexcare | Series A | $20M | Mar 2021 |
| DexCare | Series A | $20M | Mar 2021 |
| Carrum Health | Series A | $40M | Jan 2021 |
 Polyverse | Growth | $2M | May 2019 |
 AiCure | Series C | $56M | Jan 2019 |
 Saykara | Unknown | $5M | Sep 2018 |
 Hint Health | Series A | $10M | May 2018 |
 Virtudent | Series A | $8M | Jan 2018 |
 Cyrus Biotechnology | Series A | $8M | Jan 2017 |
 NextStep | Seed | $2.1M | — |
 Outbound AI | Seed | $16M | — |
 KLOwen | Series A | — | — |
| KLOwen | Series B | $25.5M | — |
| KLOwen | Series A | $10.5M | — |
 Virtudent | Series A | $8M | — |
Top Co-Investors
Last updated: 7 October 2026